DGKB, variants, traits, and what the research shows

DGKB - what this gene does

Without detailed study summaries on file, the clearest picture of this gene comes from the breadth of its association signals: variants here have been statistically linked to neurological conditions, cancer, mental health traits, liver-related phenotypes, pharmacogenomics (the study of how an individual's genetic makeup influences their response to drugs), and rare disease categories.

Key takeaways

• Variants in this gene have been linked to neurological conditions, cancer, mental health, liver traits, pharmacogenomics, and rare disease categories.
• Three separate cancer-linked variants share the highest evidence tier on file, making cancer the most represented trait domain.
• A pharmacogenomics signal suggests this gene may be relevant to research on how medications work differently across individuals.
• All associations are population-level statistical signals from large genetic studies - not individual predictions.
• No detailed study summaries are currently available for variants in this gene; all findings should be considered preliminary.

Notable variants

The ten highest-magnitude variants on file all sit at magnitude 4.50. Three are tied to cancer: rs141540350, rs6971925, and rs75164731. A neurological signal appears at rs116211416, a mental health association at rs1525085, and a pharmacogenomics signal at rs17774495. Liver-related and rare disease signals round out the top tier at rs184641397 and rs217554 respectively. Two additional top-tier variants - rs16878268 and rs181588285 - carry no trait label in the current data.

Trait associations

The associations on file span several broad health domains. Cancer appears as the most represented trait category, with three distinct high-magnitude variants - rs141540350, rs6971925, and rs75164731 - sharing the same evidence tier; multiple variants converging on a single trait domain can suggest a more robust signal, though without study summaries the specific cancer type and study designs remain unknown. Neurological conditions are flagged at rs116211416, mental health at rs1525085, liver-related phenotypes at rs184641397, and rare disease at rs217554. A pharmacogenomics signal at rs17774495 indicates potential relevance to drug response research. Ten additional variants at magnitude 3.00 carry no trait labels in the current dataset.

Evidence quality

Of 114 variants on file for this gene, the ten highest-magnitude entries sit at 4.50 and ten more sit at 3.00; the remaining 94 are not detailed here. Critically, no prior study summaries are available for any variant, meaning supporting details - such as sample sizes, odds ratios (a measure of how strongly a variant is statistically linked to a trait), beta coefficients, replication cohorts, and study designs - cannot be reported. The cancer signal carries the most apparent weight from the count of high-magnitude variants sharing that label, but multi-variant convergence alone is not a substitute for replication across independent studies. All findings should be treated as preliminary and hypothesis-generating.

What this is NOT

These variants represent population-level statistical associations discovered through GWAS (genome-wide association studies - research that scans large groups of people's genomes for patterns linked to traits) and similar methods; they are not deterministic predictors of any outcome for any individual. This encyclopedia entry does not prescribe, diagnose, or advise any course of action.